Brighton Jones LLC’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,012
Closed -$243K 560
2023
Q1
$243K Buy
5,012
+6
+0.1% +$317 0.01% 426
2022
Q4
$302K Buy
5,006
+5
+0.1% +$293 0.02% 337
2022
Q3
$303K Buy
+5,001
New +$158K 0.02% 330
2021
Q4
Sell
-4,000
Closed -$285K 548
2021
Q3
$285K Hold
4,000
0.01% 372
2021
Q2
$206K Buy
+4,000
New +$125K 0.01% 451

Other funds holding PRTA

Brighton Jones LLC's PRTA Position: Q2 2023 in Review

Brighton Jones LLC sold out of Prothena Corp (PRTA) in Q2 2023, closing a stake of 5,012 shares — an estimated $243K sold.

Brighton Jones LLC first reported a position in PRTA in Q2 2021 and held it in 5 quarters. The position peaked at $303K in Q3 2022. 196 funds tracked by Wall St. Rank hold PRTA as of Q2 2023.

  • Brighton Jones LLC reported no remaining Prothena Corp position as of Q2 2023 after selling out during the quarter.
  • Brighton Jones LLC sold 5,012 Prothena Corp shares in Q2 2023, an estimated $243K.
  • Brighton Jones LLC first reported a position in Prothena Corp in Q2 2021 and held it in 5 quarters.
  • Brighton Jones LLC's Prothena Corp position peaked at $303K in Q3 2022.
  • 196 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2023.

Based on Brighton Jones LLC's 13F filing for Q2 2023, filed 31 Jul 2023.